Determining the Correlation Between Blood Loss and Clinical Findings Among Patients with Postpartum Hemorrhage

Background: There is a need for signs that will help the midwives or the health care providers attending deliveries to prevent the patient from going into hypovolemic shock, especially when immediate testing is not possible. The study aims to find the correlation between the clinical symptoms and bl...

Full description

Saved in:
Bibliographic Details
Main Authors: Rajani Dube, Subhranshu Sekhar Kar, Sanghamitra Satapathy, Biji Thomas George, Heena Garg
Format: Article
Language:English
Published: Mary Ann Liebert 2025-01-01
Series:Women's Health Reports
Subjects:
Online Access:https://www.liebertpub.com/doi/10.1089/whr.2024.0103
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: There is a need for signs that will help the midwives or the health care providers attending deliveries to prevent the patient from going into hypovolemic shock, especially when immediate testing is not possible. The study aims to find the correlation between the clinical symptoms and blood loss in women with postpartum hemorrhage. Methods: It is a descriptive observational study conducted at the Department of Obstetrics and Gynecology, Maternity Hospitals. Women treated with either Misoprostol or Ergometrine during delivery were included in the study. Data were collected for Packed Cell Volume (PCV), Hemoglobin (Hb%), etc.; other investigations include general clinical condition, presence or absence of PPH, and amount of blood loss using laboratory reports. Results: The study has reported clinical findings and blood loss to identify the correlation between them. Only 4% of women suffered blood loss of more than 500 mL, i.e., postpartum hemorrhage (PPH) occurred among them. The change in Hb% among the majority of the women was ranging between 0–0.5 gm% (71.5%). Most cases (72.72%) had tachycardia followed by palpitation (10.90%). Blood loss exceeding 1500 mL was correlated with hypotension, restlessness, and oliguria. Conclusions: Extra vigilance is needed to identify women at risk and facilitate early intervention and treatment of PPH.
ISSN:2688-4844